Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

Carmen Criscitiello, Giulia Viale, Giuseppe Curigliano, Aron Goldhirsch European Institute of Oncology, Milano, Italy Abstract: Alteration of the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin signaling pathway is key for the growth and survival of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Criscitiello C, Viale G, Curigliano G, Goldhirsch A
Format: article
Langue:EN
Publié: Dove Medical Press 2018
Sujets:
Accès en ligne:https://doaj.org/article/d5bcc36067914069a34e9071aacf3d50
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires